Evidence map›Paper›PMID 28750485›Full record

ArticleGut and liver2017

Jun-Won Chung, Su Young Kim, Hee Jung Park, Chang Su Chung, Hee Woo Lee, Sun Mi Lee, Inki Kim, Jhang Ho Pak, Gin Hyug Lee, Jin-Yong Jeong

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gut and liver, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Tailored eradicationWorld journal of gastroenterology · 2019
    Article
  4. Rifabutin and Furazolidone Could Be the Candidates of the Rescue Regimen for Antibiotic-ResistantThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jun-Won ChungDivision of Gastroenterology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Su Young KimDivision of Gastroenterology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Hee Jung ParkDepartment of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Chang Su ChungDivision of Gastroenterology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Hee Woo LeeDivision of Gastroenterology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Sun Mi LeeDepartment of Convergence Medicine and Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Inki KimDepartment of Convergence Medicine and Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Jhang Ho PakDepartment of Convergence Medicine and Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Gin Hyug LeeDepartment of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Jin-Yong JeongDepartment of Convergence Medicine and Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Gachon University Gil Medical Center · KRUniversity of Ulsan · KRAsan Medical Center · KRUlsan College · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsThe increased resistance of

methodsWe screened a small molecule library-the library of pharmacologically active compounds (LOPAC), which includes 1,280 pharmacologically active compounds-to identify inhibitors of

resultsWe identified diphenyleneiodonium (DPI) as a novel anti-

conclusionsDPI may be a candidate anti-

Indexed as

Anti-Bacterial AgentsDrug Resistance, Multiple, BacterialHelicobacter InfectionsHelicobacter pyloriHumansMicrobial Sensitivity TestsOnium CompoundsAnti-Bacterial AgentsdiphenyleneiodoniumOnium CompoundsAnti-bacterial agentsDiphenyleneiodoniumDrug resistance, multipleHelicobacter pyloriMinimal inhibitory concentration

Identifiers

PMID28750485
PMCPMC5593327
OpenAlexW2739949278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.